Seeking Alpha

rml360

rml360
Send Message
View as an RSS Feed
View rml360's Comments BY TICKER:
Latest  |  Highest rated
  • Weighing The Pros And Cons Of InVivo Therapeutics [View article]
    Is Napa valley still around? what is his problem? if he has info he should share it
    Apr 23, 2014. 07:26 PM | Likes Like |Link to Comment
  • Weighing The Pros And Cons Of InVivo Therapeutics [View article]
    Well, one of your wishes came true, they pulled the investor presentation from the corporate website

    Quote: Not to mention, the company has been largely radio-silent over the past six months, having not even updated its investor presentation since the Aegis Capital Healthcare Conference in September 2013.
    Mar 26, 2014. 12:11 PM | Likes Like |Link to Comment
  • CAPTURE Data Should Help Drive Soltamox Sales At DARA Bio [View article]
    yes, we all make mistakes
    Mar 24, 2014. 09:18 AM | Likes Like |Link to Comment
  • Weighing The Pros And Cons Of InVivo Therapeutics [View article]
    Its amazing your articles that spit out the same info from 6 months ago get the stock moving the way it does. On twitter, you said you would write an article when the trial starts, oh well, premature ej. on that one. Yes, it is sad, the situation we are in with the delay, however doesn't change the view I have of the company. I believe they will partner the gel in Q2, which will give them enough upfront cash to make through at least 2 successful cycles of the scaffold. Perhaps i am putting to much faith in the current management, but rather faith in them, than you.
    Mar 21, 2014. 12:18 PM | Likes Like |Link to Comment
  • CAPTURE Data Should Help Drive Soltamox Sales At DARA Bio [View article]
    Jnap-stick to nviv coverage, dara is a loser
    Mar 20, 2014. 03:50 PM | Likes Like |Link to Comment
  • A Stock That May Rally $20 In 3-Months [View instapost]
    short interest is up again, I see, let them burn, including fraudstain and his cronies. Can't wait to see that live blog:

    AF: Here comes the vote:

    1 yes
    2 yes
    3 yes
    4 yes
    5 yes
    6 yes

    AF: Geez, not sure what the panel sees here? Its just fish oil

    7 yes
    8 yes

    AF: GSK stock sinking 1.5%, not sure why

    amrn_investor: shove it

    AF: $amrn stock up 25-30% after hours, not sure why
    Sep 30, 2013. 07:11 PM | 2 Likes Like |Link to Comment
  • A Stock That May Rally $20 In 3-Months [View instapost]
    you hear anything about the ATP4 guidelines getting published by year end? and if so, how does it impact Amarin? I know biobill put in his 2 cents
    Sep 30, 2013. 01:18 PM | 1 Like Like |Link to Comment
  • AF Backtracking, AMRN Will Be Approved On Time [View instapost]
    lovaza is a billion dollar drug, period, vascepa will be. AF says that docs don't believe in fish oil, while most patients with moderate to high trigs on statins are taking fish oil to supplement statins

    Vascepa data shows 1st in class, outperforms lovaza

    nuff said
    Sep 26, 2013. 09:42 AM | 1 Like Like |Link to Comment
  • AF Backtracking, AMRN Will Be Approved On Time [View instapost]
    Steve,
    I know NCE is a sensitive subject, last time I read your board, you mentioned in April that Amarin was making some success with the exclusivity board, however the decision would be postponed to december timeframe due to resources. Has anything changed on this? Could we still get an update in Oct? Have you been in touch with anyone recently?
    Sep 24, 2013. 01:54 PM | Likes Like |Link to Comment
  • Explosive Bidding Situation Setting Up For Amarin [View instapost]
    1) by submitting the combo, they automatically get 3 years of exclusivity, so even if they don't even get one patent, they get 3 years for free
    2) not necessarily, the fda might ask azn to do a small study to confirm that it works, then submit for nda, although you make a valid point, however one which azn I am sure thought of before they wrote a check for 500 million
    Sep 19, 2013. 08:31 AM | Likes Like |Link to Comment
  • Explosive Bidding Situation Setting Up For Amarin [View instapost]
    Surprisingly, I don't think AZN will market Epanova for the high trigs market, I think they will get approval and combo it with crestor, and sell the combo drug when the patents expire--It would be a waste of money to market the same drug with a generic lovaza--there would be no incentive to switch to full price
    Sep 18, 2013. 02:20 PM | 1 Like Like |Link to Comment
  • Yet More New Developmetn Re; Amarin [View instapost]
    respectfully disagree, it will come before, optimistically before ADCOM, conservative before pduda
    then after pfuda in Jan 2014, Anchor will recieve NME with 3 years, no matter though, 5 years with Marine will do
    I don't think (just my opinion) fda wants NCE topic discussed during ADCOM, put it to bed before panel
    Aug 29, 2013. 12:46 PM | 1 Like Like |Link to Comment
  • Yet More New Developmetn Re; Amarin [View instapost]
    although JZ disagrees with me, NCE determination will be cataylst for everything. It will rocket us 100% immediately, and potential suitors will pull trigger, or wait for adcom, then pull trigger, all depends on when decision gets issued.
    Aug 29, 2013. 12:01 PM | 2 Likes Like |Link to Comment
  • Amarin Update After CC [View instapost]
    Steve, can you find out if the removal of NCE determination means the decision is coming sooner or did they decide to take it off due to all the questions they have been getting or not knowing when the decision will be made, so they removed it from the presentation
    Aug 16, 2013. 07:16 PM | Likes Like |Link to Comment
  • InVivo Therapeutics tumbles on up-listing delay [View news story]
    indefinately means minor delay?
    Jul 31, 2013. 02:33 PM | Likes Like |Link to Comment
COMMENTS STATS
25 Comments
0 Likes